<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               4 CONTRAINDICATIONS<BR>               <BR>                  Letrozole tablets may cause fetal harm when administered to a <BR>pregnant woman and the clinical benefit to premenopausal women with breast <BR>cancer has not been demonstrated. Letrozole tablets are contraindicated in women <BR>who are or may become pregnant. If letrozole tablets are used during pregnancy, <BR>or if the patient becomes pregnant while taking this drug, the patient should be <BR>apprised of the potential hazard to a fetus [see Use in Specific <BR>Populations (8.1)]. <BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        Women of premenopausal endocrine status, including pregnant women <BR>(4) <BR><BR>                        <BR><BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>